Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate. [electronic resource]
Producer: 20161103Description: 144-50 p. digitalISSN:- 1872-213X
- Administration, Inhalation
- Administration, Oral
- Adrenal Cortex Hormones -- administration & dosage
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Age Factors
- Androstadienes -- administration & dosage
- Animals
- Anti-Asthmatic Agents -- administration & dosage
- Asthma -- drug therapy
- Benzyl Alcohols -- administration & dosage
- Biological Availability
- Bronchoconstriction -- drug effects
- Bronchodilator Agents -- administration & dosage
- Chlorobenzenes -- administration & dosage
- Drug Administration Schedule
- Drug Combinations
- Drug and Narcotic Control
- Humans
- Lung -- drug effects
- Patents as Topic
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.